Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1223 |
| Name of the vaccine | NDBR 101 |
| Microbe | Bacteria |
| Disease name | Tularemia (Rabbit fever) |
| Name of bacteria | Francisella tularensis |
| Type of vaccine | Live attenuated |
| Nucleic acid content | Circular DNA |
| Age | 18 to 65 years |
| Description of the vaccine | Tularemia vaccine. |
| Name of the manufacturer | U.S. Army Medical Research and Development Command |
| Name of the manufacturing country | United States |
| Year of manufacture | 2021 |
| Clinical Phase status | Clinical - Phase 2 |
| Bacterial strain | Gram-negative bacteria. |
| Efficacy | NA |
| Vaccine formulation | NA |
| Dosage | Two doses of 0.0025 mL. |
| Mechanism of action | NA |
| Route of administration | Percutaneous |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | NA |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | NA |
| Interspecies transfer | Yes (through the bite of infected insects) |
| PubMed identifier | NA |
| Clinical trial number | NCT00787826 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |